Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-070142

Chief Scientific Officer sold 1,068 shares at $7.81 ($8,341)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Scientific Officer 2023-12-12 Sale −1,068 $7.81 $8,341 88,965 D: show line 1 in the form
Open-market sales · 1,068 sh · avg $7.81 · $8,341
Loading xslF345X05/ownership.xml…